The following biotech stocks that were featured on our website reached new highs on Thursday. Were those stocks in your investment portfolio and have you capitalized on the surge?
*Last Closing Price refers to the closing price of the stock on Jun.8, 2023.
Ticker
Published Date
Published Price
Maximum Price Since Publication
*Last Closing Price
Maximum Gain %
Biomea Fusion, Inc. (BMEA)
Jan.30, 2023
$9.32
$43.68
$41.80
368%
Exact Sciences Corp. (EXAS)
Nov.7, 2022
$37.80
$91.19
$90.65
141%
AVITA Medical Inc. (RCEL)
Feb.10, 2023
$9.42
$17.45
$16.55
85%
Aldeyra Therapeutics Inc. (ALDX)
Jul.12, 2023
$4.55
$11.91
$11.89
161%
CONMED Corp. (CNMD)
Nov.15, 2022
$91.05
$133.13
$131.68
46%
ImmunoGen Inc. (IMGN)
Jul.15, 2022
$5.43
$15.84
$15.75
191%
Tarsus Pharmaceuticals Inc. (TARS)
Sep.29, 2022
$17.58
$20.09
$19.63
14%
Morphic Holding Inc. (MORF)
Nov.17. 2022
$28.42
$62.49
$62.11
119%
Krystal Biotech Inc. (KRYS)
Nov.9, 2022
$77.84
$129.48
$128
66%
Protagonist Therapeutics Inc. (PTGX)
Mar.7, 2023
$16.97
$29.42
$29.36
73%
IDEAYA Biosciences Inc. (IDYA)
Mar.11, 2022
$13.30
$25.68
$25.53
93%
Rocket Pharmaceuticals Inc. (RCKT)
Sep.14, 2022
$14.11
$23.64
$23.46
67%
Prometheus Biosciences, Inc. (RXDX)
Oct.3. 2022
$61.08
$199.20
$198.98
226%
For comments and feedback contact: editorial@rttnews.com
Business News
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.